HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Serine phosphorylation proximal to its phosphotyrosine binding domain inhibits insulin receptor substrate 1 function and promotes insulin resistance.

Abstract
Ser/Thr phosphorylation of insulin receptor substrate (IRS) proteins negatively modulates insulin signaling. Therefore, the identification of serine sites whose phosphorylation inhibit IRS protein functions is of physiological importance. Here we mutated seven Ser sites located proximal to the phosphotyrosine binding domain of insulin receptor substrate 1 (IRS-1) (S265, S302, S325, S336, S358, S407, and S408) into Ala. When overexpressed in rat hepatoma Fao or CHO cells, the mutated IRS-1 protein in which the seven Ser sites were mutated to Ala (IRS-1(7A)), unlike wild-type IRS-1 (IRS-1(WT)), maintained its Tyr-phosphorylated active conformation after prolonged insulin treatment or when the cells were challenged with inducers of insulin resistance prior to acute insulin treatment. This was due to the ability of IRS-1(7A) to remain complexed with the insulin receptor (IR), unlike IRS-1(WT), which underwent Ser phosphorylation, resulting in its dissociation from IR. Studies of truncated forms of IRS-1 revealed that the region between amino acids 365 to 430 is a main insulin-stimulated Ser phosphorylation domain. Indeed, IRS-1 mutated only at S408, which undergoes phosphorylation in vivo, partially maintained the properties of IRS-1(7A) and conferred protection against selected inducers of insulin resistance. These findings suggest that S408 and additional Ser sites among the seven mutated Ser sites are targets for IRS-1 kinases that play a key negative regulatory role in IRS-1 function and insulin action. These sites presumably serve as points of convergence, where physiological feedback control mechanisms, which are triggered by insulin-stimulated IRS kinases, overlap with IRS kinases triggered by inducers of insulin resistance to terminate insulin signaling.
AuthorsYan-Fang Liu, Avia Herschkovitz, Sigalit Boura-Halfon, Denise Ronen, Keren Paz, Derek Leroith, Yehiel Zick
JournalMolecular and cellular biology (Mol Cell Biol) Vol. 24 Issue 21 Pg. 9668-81 (Nov 2004) ISSN: 0270-7306 [Print] United States
PMID15485932 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • IRS1 protein, human
  • Insulin
  • Insulin Receptor Substrate Proteins
  • Irs1 protein, mouse
  • Irs1 protein, rat
  • Phosphoproteins
  • Proto-Oncogene Proteins
  • Phosphoserine
  • Phosphotyrosine
  • Serine
  • Protein Serine-Threonine Kinases
  • Proto-Oncogene Proteins c-akt
  • Mitogen-Activated Protein Kinases
Topics
  • Adenoviridae (genetics)
  • Animals
  • Binding Sites
  • Cell Line
  • Cricetinae
  • Enzyme Activation
  • Gene Expression Regulation, Viral
  • Genes, myc (genetics)
  • Humans
  • Insulin (pharmacology)
  • Insulin Receptor Substrate Proteins
  • Insulin Resistance
  • Mice
  • Mitogen-Activated Protein Kinases (metabolism)
  • Mutation (genetics)
  • Phosphoproteins (antagonists & inhibitors, genetics, metabolism)
  • Phosphorylation
  • Phosphoserine (metabolism)
  • Phosphotyrosine (metabolism)
  • Protein Serine-Threonine Kinases (metabolism)
  • Proto-Oncogene Proteins (metabolism)
  • Proto-Oncogene Proteins c-akt
  • Serine (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: